Does knowing your molecular mutation in earlier stage lung cancer have any significance in selecting a treatment modality? Is there any difference between external and internal factors that lead to gene mutations in lung cancer? Live from the 2016 American Society of Clinical Oncology (ASCO) meeting in Chicago, Drs. Liza Villaruz and Charu Aggarwal sat down with host, John Ratzenberger, for an Ask the Lung Cancer Expert discussion that covered questions submitted by lung cancer patients and their families.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo